Loading…
Back To Schedule
Tuesday, September 20 • 9:15am - 10:00am
Opening Panel: Effective Forecasting for New Products

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
  • Expand on stage/phase specific forecasts and the benefits of regularly updating the forecast
  • Evaluate the different resources available for the forecast and the best ones to utilize at each stage to maintain accuracy
  • Understand the value of incorporating real-world evidence from health economics and outcomes research into the forecasting model
Speakers
avatar for Guru Muralimohan, PhD

Guru Muralimohan, PhD

Senior Director, Early Pipeline Commercialization (SBU Oncology), Bayer
Guru Muralimohan is a global commercial leader with strong scientific background and broad experience in strategic marketing, new product planning, launch excellence, and market access.  At Bayer Pharmaceuticals, Guru is the global early pipeline commercial lead for the Immuno-oncology... Read More →
avatar for Sarah Jims, PhD

Sarah Jims, PhD

Principal, Triangle Insights Group, LLC
Sarah Jims is a Principal at Triangle Insights Group with over a decade of experience in the life sciences industry. In her role, Sarah serves as an experienced consultant to leaders of biotechnology and pharmaceutical organizations in commercial assessment, portfolio strategy, commercialization... Read More →
avatar for Simran Madan, Ph.D.

Simran Madan, Ph.D.

Director - Product and Portfolio Commercial Strategy, 2seventy bio
Simran is Director of Product and Portfolio Commercial Strategy 2seventy bio. In this role, Simran serves as the commercial lead on all clinical and pre-clinical assets at 2seventy and shapes the early oncology portfolio. She also oversees the CI as well as forecasting and analytics... Read More →
avatar for William Lumpkin

William Lumpkin

Former Head of New Product Strategy, Alexion Pharmaceuticals

Tuesday September 20, 2022 9:15am - 10:00am EDT
  General Session